Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-23T04:43:39.909Z Has data issue: false hasContentIssue false

Role of limited parotidectomy in management of pleomorphic adenoma

Published online by Cambridge University Press:  01 August 2007

J T Johnson
Affiliation:
Department of Otolaryngology, School of Medicine, University of Pittsburgh, Pennsylvania, USA
A Ferlito*
Affiliation:
ENT Clinic, Department of Surgical Sciences, University of Udine, Italy
J J Fagan
Affiliation:
Division of Otolaryngology, Faculty of Health Sciences, University of Cape Town, South Africa
P J Bradley
Affiliation:
Department of Otorhinolaryngology-Head and Neck Surgery, Queen's Medical Centre, Nottingham, UK
A Rinaldo
Affiliation:
ENT Clinic, Department of Surgical Sciences, University of Udine, Italy
*
Address for correspondence: Professor Alfio Ferlito, Director of the Department of Surgical Sciences, Professor and Chairman of the ENT Clinic, Policlinico Universitario, University of Udine, Piazzale S Maria della Misericordia, I-33100 Udine, Italy. Fax: +39 0432 559339 E-mail: a.ferlito@uniud.it

Abstract

There is continued controversy over the extent of parotidectomy required for removal of a benign pleomorphic adenoma from the parotid gland. Currently, consensus exists that the integrity of the facial nerve must be preserved when the tumour is totally removed.

As a result of experience gained in the first half of the twentieth century, it was recommended that superficial parotidectomy with facial nerve dissection should be the minimal biopsy for pleomorphic adenoma. Since that time, however, research has indicated that partial parotidectomy or extracapsular dissection of benign pleomorphic adenoma can be accomplished with preservation of the facial nerve without an increase in tumour recurrence. Partial parotidectomy or extracapsular dissection results in impaired cosmetic results and a lower incidence of Frey's syndrome, and thus may be the preferred approach when undertaken by experienced surgeons.

Type
Review Articles
Copyright
Copyright © JLO (1984) Limited 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Spiro, RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 1986;8:177–84CrossRefGoogle ScholarPubMed
2 Bradley, PJ. ‘Metastasizing pleomorphic salivary adenoma’ should now be considered a low-grade malignancy with a lethal potential. Curr Opin Otolaryngol Head Neck Surg 2005;13:123–6CrossRefGoogle ScholarPubMed
3 Nouraei, SAR, Ferguson, MS, Clarke, PM, Sandison, A, Sandhu, GS, Michaels, L et al. Metastasizing pleomorphic salivary adenoma. Arch Otolaryngol Head Neck Surg 2006;132:788–93CrossRefGoogle ScholarPubMed
4 Bradley, PJ. Recurrent salivary gland pleomorphic adenoma: etiology, management, and results. Curr Opin Otolaryngol Head Neck Surg 2001;9:100–8CrossRefGoogle Scholar
5 Benedict, EB, Meigs, JV. Tumors of the parotid gland: A study of two hundred and twenty-five cases with complete end-results in eighty cases. Surg Gynecol Obstet 1930;51:626–47Google Scholar
6 McFarland, J. Three hundred mixed tumors of the salivary glands, of which sixty-nine recurred. Surg Gynecol Obstet 1936;63:457–68Google Scholar
7 Rawson, AJ, Howard, JM, Royster, HP, Horn, RC Jr. Tumors of the salivary glands: a clinicopathological study of 160 cases. Cancer 1950;3:445–583.0.CO;2-U>CrossRefGoogle ScholarPubMed
8 McFarland, J. Mysterious mixed tumors of salivary glands. Surg Gynecol Obstet 1943;76:2334Google Scholar
9 Patey, DH, Thackray, AC. The treatment of parotid tumours in the light of a pathological study of parotidectomy material. Br J Surg 1958;45:477–87CrossRefGoogle ScholarPubMed
10 Donovan, DT, Conley, JJ. Capsular significance in parotid tumor surgery: reality and myths of lateral lobectomy. Laryngoscope 1984;94:324–9CrossRefGoogle ScholarPubMed
11 Dallera, P, Marchetti, C, Campobassi, A. Local capsular dissection of parotid pleomorphic adenomas. Int J Oral Maxillofac Surg 1993;22:154–7CrossRefGoogle ScholarPubMed
12 McGurk, M, Renehan, A, Gleave, EN, Hancock, BD. Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas. Br J Surg 1996;83:1747–9CrossRefGoogle ScholarPubMed
13 Hancock, BD. Clinically benign parotid tumours: local dissection as an alternative to superficial parotidectomy in selected cases. Ann R Coll Surg Engl 1999;81:299301Google ScholarPubMed
14 Witt, RL. The significance of the margin in parotid surgery for pleomorphic adenoma. Laryngoscope 2002;112:2141–54CrossRefGoogle ScholarPubMed
15 McGurk, M, Thomas, BL, Renehan, AG. Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise. Br J Cancer 2003;89:1610–13CrossRefGoogle ScholarPubMed
16 Iizuka, K, Ishikawa, K. Surgical techniques for benign parotid tumors: segmental resection vs extracapsular lumpectomy. Acta Otolaryngol Suppl 1998;537:7581Google ScholarPubMed
17 Stennert, E, Guntinas-Lichius, O, Klussmann, JP, Arnold, G. Histopathology of pleomorphic adenoma in parotid gland: a prospective unselected series of 100 cases. Laryngoscope 2001;111:2195–200CrossRefGoogle ScholarPubMed
18 Wen, Y, Chen, R, Wang, C. The pathologic basis of partial parotidectomy in parotid pleomorphic adenoma treatment [in Chinese]. Hua Xi Kou Qiang Yi Xue Za Zhi 2003;21:359–60Google ScholarPubMed
19 O'Brien, CJ. Current management of benign parotid tumors – the role of limited superficial parotidectomy. Head Neck 2003;25:946–52CrossRefGoogle ScholarPubMed
20 Kornevs, E, Tars, J, Bigestans, A, Lauskis, G. Treatment of parotid gland tumors in Latvian Oncological Center. Stomatologija 2005;7:110–14Google ScholarPubMed
21 Bradley, PJ. Pleomorphic salivary adenoma of the parotid gland: which operation to perform? Curr Opin Otolaryngol Head Neck Surg 2004;12:6970CrossRefGoogle ScholarPubMed